AUNIP and adrenal cortex carcinoma: Immune checkpoint is the target of immunotherapy at this stage, and our results showed that AUNIP was positively or negatively associated with an immune checkpoint in all tumors except ACC, CESC, CHOL, MESO, OV, and UCS (Fig. 6C).